AstraZeneca statement from WHO |  NTV

AstraZeneca statement from WHO | NTV


The World Health Organization (WHO) reported that more than 300 million doses of new types of corona virus (Covid-19) vaccine developed by different companies globally were applied and no vaccine-related deaths were detected.

Tedros Adhanom Ghebreyesus, Director-General of WHO, held a press conference at the organization’s headquarters in Geneva, Switzerland, using video conferencing.

Ghebreyesus stated that the WHO Global Vaccine Safety Advisory Committee will meet tomorrow after the use of the Covid-19 vaccine developed by AstraZeneca is stopped in some countries.

Stating that the Committee is in contact with the European Union’s (EU) drug regulator, the European Medicines Agency (EMA), Ghebreyesus said:

“But the biggest threat most countries are facing right now is the lack of access to Covid-19 vaccines. I get calls from top politicians around the world almost every day and they ask me when to get vaccines under COVAX. I understand why. They see that some of the richest countries in the world are buying enough vaccines to vaccinate their populations over and over again, while there are no vaccines in their home country. “

“DO NOT PANIC”

After Ghebreyesus’s speech, chief expert Dr. Soumya Swaminathan shared the information, “After more than 300 million doses of different (Covid-19) vaccines have been administered worldwide, there are no documented deaths associated with Covid-19 vaccines”.

Swaminathan called on people using AstraZeneca and other vaccines to “not panic.”

Reminding that the Covid-19 virus caused the death of millions of people, Swaminathan underlined that vaccination is essential to end the epidemic.

Some countries have started to stop the use of the vaccine since last week on the grounds that the Covid-19 vaccine developed by AstraZeneca caused blood clotting in the few people who were administered.

WHO recommended on February 10 that the Covid-19 vaccine developed by Oxford-AstraZeneca be used in adults, including people over the age of 65.


Leave a Reply

Your email address will not be published. Required fields are marked *